We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

As Dr. Robby reaches hour five of his shift, we get a few more defining details about his life outside of being an easygoing ...

Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen ...

The CDC reports about 100,000 people in the United States are affected by Sickle cell disease, and more than 90% are non-Black or African American. One local organization is aiming to shed light on ...

A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also known as exa-cel, was the first treatment to be licensed using gene ...

Gallbladder problems are a common complication in individuals with sickle cell disease. These issues often arise due to the breakdown of red blood cells and the subsequent formation of gallstones ...

For those living with sickle cell disease, daily life is a series of obstacles that demand unwavering strength. The condition is relentless, marked by excruciating pain crises, organ damage ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

They were on hand to celebrate the ribbon cutting of the Crescent Club Book Club for sickle cell patients at Cardinal Glennon Children’s Hospital on Monday, January 20, 2025. Photo courtesy SSM ...

Would the transplant work? What would it look like to have a successful stem cell transplant? Would it be a cure for my sickle cell disease? It was a decision I could think about making because my ...

A sickle cell disease “cure” is to be offered to NHS patients for the first time. The £1.65 million gene therapy called exa-cel, also known under the brand name Casgevy, uses a Nobel Prize ...